Thirona Spinout Thirona Retina BV Acquired by Revenio Group
Aleksandra Boers-Pyra2024-08-20T13:39:56+00:00Divestment of Thirona Retina BV to continue focus on pulmonary diseases and expanding within the interventional pulmonology space
Welcoming top clinical experts to Thirona’s Medical Advisory Board
Aleksandra Boers-Pyra2024-08-15T16:08:02+00:00To achieve our mission of advancing personalized and tailored approaches to lung disease treatment and care, we are welcoming top clinical experts to Thirona's Medical Advisory Board.
Thirona partners with Free Flow Medical for AI-powered clinical solutions to treat COPD patients
Aleksandra Boers-Pyra2024-02-19T12:50:29+00:00Thirona and Free Flow Medical signed a partnership agreement to provide clinicians with advanced high-precision tools for treatment planning.
Thirona and Pulmonx have extended their strategic partnership, which leverages Thirona’s AI-powered solutions in Pulmonx StratX® platform
Aleksandra Boers-Pyra2024-02-19T11:28:34+00:00Thirona BV and Pulmonx Corporation have extended their long-running strategic partnership.
Thirona closes financing round with HERAN Partners and Borski Fund
Aleksandra Boers-Pyra2024-02-19T11:27:21+00:00We are proud to inform that we have just closed a financing round with Belgian investment fund HERAN Partners and Borski Fund from the Netherlands.
Thirona is at the ATS conference
Aleksandra Boers-Pyra2024-02-19T11:02:47+00:00Thirona is present at the ATS 2019 from 17-22 May in Dallas, TX. Visit our booth #3022 and learn about our lung quantification software based on artificial intelligence.
CAD4TB v6 evaluation paper
Aleksandra Boers-Pyra2022-04-04T12:20:27+00:00The paper demonstrates that this latest version of CAD4TB outperforms all previous versions; the software is now operating at the level of expert human readers in detecting TB from chest X-Ray.
